TITLE

Analysis of Both NM23-H1 and NM23-H2 Expression Identifies "At-Risk" Patients with Colorectal Cancer

AUTHOR(S)
Brenner, Antonio S.; Senagore, Anthony J.; Duepree, Hans-Joachim; Gramlich, Terry; Fazio, Victor W.; Thebo, Jennifer S.; Ormsby, Adrian; Lavery, Ian C.
PUB. DATE
March 2003
SOURCE
American Surgeon;Mar2003, Vol. 69 Issue 3, p203
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Metastasis is the manifestation most directly affecting survival for patients with colorectal carcinoma. Identification of high-risk markers for metastases would allow focused selection of patients for adjuvant chemotherapy. Reports of the relationship between the putative metastasis suppressor NM23 and metastasis and/or survival in colorectal cancer patients are conflicting. The purpose of this study was to separately assess expression of NM23-H1 and NM23-H2 in primary colon cancers and determine whether expression was associated with regional nodal disease and/or liver metastases. Four patient cohorts were selected on the basis of histopathological staging at primary surgery (lymph node status/liver metastasis): -/- (n = 46), +/- (n = 47), -/+ (n = 43), and +/+ (n = 46). Primary tumors were evaluated by semiquantitative immunohistochemical analysis of NM23-H1 and NM23-H2. NM23-H2 expression was not related to survival; however, there was a modest survival advantage with low expression of NM23-H1 (P = 0.027). NM23-H1 expression in the +/+ group was increased compared with the other groups (P < 0.001). The -/+ group had the lowest expression of NM23-H2 (P < 0.001). This analysis distinguishes two high-risk groups of colorectal cancer patients. Prior discrepancies regarding the usefulness of NM23 staining may be explained by the need to evaluate both serotypes in addition to standard histopathological analysis to identify specific "at-risk" groups.
ACCESSION #
10544958

 

Related Articles

  • Advances in the surgical treatment of colorectal cancer liver metastases through ultrasound. Torzilli, Guido // Surgery Today;Sep2011, Vol. 41 Issue 9, p1184 

    Surgery remains the gold standard of treatment for colorectal cancer liver metastases (CLM). The only limitation of surgery for CLM is its technical feasibility, the key point being to leave enough remnant liver to ensure patient survival. This report describes a surgical procedure based...

  • Treatment for multiple bilobar liver metastases of colorectal cancer. Shimada, Hiroshi; Tanaka, Kuniya; Matsuo, Kenichi; Togo, Shinji // Langenbeck's Archives of Surgery;Apr2006, Vol. 391 Issue 2, p130 

    Background: Recent advances have extended indications for hepatectomy to include multiple bilobar colorectal liver metastases (CLM). Staging systems based on the biological malignancy of primary and metastatic tumors provide appropriate indications for hepatectomy in CLM. However, suitability...

  • Ten-Year Survival after Liver Resection for Colorectal Metastases: Systematic Review and Meta-Analysis. Abbas, Saleh; Lam, Vincent; Hollands, Michael // ISRN Oncology;2011, p1 

    Background. Liver resection in metastatic colorectal cancer is proved to result in five-year survival of 25-40%. Several factors have been investigated to look for prognostic factors stratifications such as resection margins, node involvement in the primary disease, and interval between the...

  • A Perforated Colonic Neuroendocrine Tumor with Liver Metastasis: A Case Report and Literature Review. Alshammari, Turki F.; Hakami, Riyadh Ali; Alali, Mohammed N.; AlShammari, Sulaiman; Zayed, Mohammed Ayesh; AlSohaibani, Mohammed Omar; Traiki, Thamer Bin // American Journal of Case Reports;6/28/2019, Vol. 20, p920 

    Objective: Unusual clinical course. Background: Neuroendocrine neoplasms (NENs) originate from cells of the endocrine and nervous systems, and they are rarely encountered in colorectal cases with no specific symptoms. The incidence and prevalence of NENs of the large bowel are increasing....

  • Expression of Peroxisome Proliferator-Activated Receptor-γ in Colon Cancer: Correlation with Histopathological Parameters, Cell Cycle-Related Molecules, and Patients’ Survival. Stamatios Theocharis; Aikaterini Parasi; Alexandra Margeli; John Kakisis; Emmanuel Agapitos; Gregorios Kouraklis // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2305 

    Abstract  Peroxisome proliferator-activated receptor γ (PPAR-γ), a ligand-activated transcription factor, is a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-γ ligands have recently been demonstrated to affect proliferation and...

  • Morphological changes in hepatic vascular endothelium after carbon dioxide pneumoperitoneum in a murine model. Izumi, K.; Ishikawa, K.; Shiroshita, H.; Matsui, V.; Shiraishi, N.; Kitano, S.; Matsui, Y // Surgical Endoscopy;Apr2005, Vol. 19 Issue 4, p554 

    Background: Liver metastasis is an important prognostic factor in advanced colorectal cancer. Several studies have demonstrated that carbon dioxide (CO2) pneumoperitonem enhances liver metastasis in an animal model. In the present study, we used scanning electron microscopy (SEM) to...

  • Hepatic resection for metastasis from colorectal cancer. Ji, Z.-L.; Peng, S.-Y.; Yuan, A.-J.; Li, P.-J.; Zhang, W.; Yu, Y. // Techniques in Coloproctology;Nov2004 Supplement 1, Vol. 8, ps47 

    Background Liver metastases from colorectal cancer are treatable and potentially curable when hepatic resection is applied. This paper is to illustrate surgical treatment of metastatic colorectal cancer in China. Patients and methods Between January 1993 and December 2002, 485 patients with...

  • Predictors and outcome of early recurrence after resection of hepatic metastases from colorectal cancer. Kaibori, Masaki; Iwamoto, Yoshinori; Ishizaki, Morihiko; Matsui, Kosuke; Yoshioka, Kazuhiko; Asano, Hiroaki; Kwon, A-Hon // Langenbeck's Archives of Surgery;Mar2012, Vol. 397 Issue 3, p373 

    Purpose: This study aimed to investigate the risk factors for early recurrence in patients who had undergone curative resection of colorectal liver metastases (CRLM) and to evaluate the outcome after recurrence. Methods: A total of 119 patients were divided into 2 groups: an early recurrence...

  • Relation between depression and circulating immune products in patients with advanced colorectal cancer. Allen-Mersh, T. G.; Glover, Clare; Fordy, Carol; Henderson, D. C.; Davies, M. // Journal of the Royal Society of Medicine;Aug1998, Vol. 91 Issue 8, p408 

    We have previously suggested that colorectal liver metastases might produce 'toxins' that reduce both quality of life (QoL) and survival. In this study we assessed whether QoL in patients with such metastases was related to immune activation, as determined by increased serum levels of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics